Zydus Cadila and Lilly Enter US$300 M Research Pact

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 3 (Table of Contents)

Published: 31 Mar-2009

DOI: 10.3833/pdr.v2009.i3.1085     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Zydus Cadila entered into an agreement with Eli Lilly & Co to discover and develop new drugs focused on treating cardiovascular diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details